Literature DB >> 1595102

Stroke and Parkinson's disease.

R L Levine1, J C Jones, N Bee.   

Abstract

BACKGROUND AND
PURPOSE: We sought to determine whether the recently reported decreased incidence of stroke and atherosclerotic disease in a university hospital-based Parkinson's disease patient population would be demonstrated in our patient population.
METHODS: We performed a retrospective case-control review of the last 119 Parkinson's disease patients discharged from the Middleton Veterans Affairs Hospital Neurology Service to study the incidence of ischemic stroke, myocardial ischemia, tobacco use, and other stroke risk factors. Controls were age and sex matched and were randomly taken from 238 non-Parkinson's disease discharges in which stroke or myocardial infarction was not the reason for hospitalization.
RESULTS: The cumulative incidences of ischemic stroke, hypertension, and diabetes mellitus were not significantly different between groups. Myocardial infarction, coronary artery disease, tobacco use, atrial fibrillation, cancer, and ethanol abuse were significantly more prevalent in the controls, whereas dementia and congestive heart failure were the only variables studied that were more prevalent in the Parkinson's disease patients.
CONCLUSIONS: Our study failed to demonstrate that Parkinson's disease patients from a Veteran population were protected from ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595102     DOI: 10.1161/01.str.23.6.839

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Impaired mitophagy at the heart of injury.

Authors:  Roberta A Gottlieb; Robert M Mentzer; Phyllis-Jean Linton
Journal:  Autophagy       Date:  2011-12       Impact factor: 16.016

Review 2.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

3.  Parkinson's disease and cerebrovascular disease: is there a link? A neurosonological case-control study.

Authors:  Sandro Zambito Marsala; Manuela Gioulis; Michele Pistacchi; Cecilia Lo Cascio
Journal:  Neurol Sci       Date:  2016-07-09       Impact factor: 3.307

4.  Taste responses in patients with Parkinson's disease.

Authors:  H Sienkiewicz-Jarosz; A Scinska; W Kuran; D Ryglewicz; A Rogowski; E Wrobel; A Korkosz; A Kukwa; W Kostowski; P Bienkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

Review 5.  Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.

Authors:  Sandeep Xxxx; Mir Hilal Ahmad; Linchi Rani; Amal Chandra Mondal
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

Review 6.  Parkinson disease and comorbid cerebrovascular disease.

Authors:  Wandana Nanhoe-Mahabier; Karlijn F de Laat; Jasper E Visser; Jan Zijlmans; Frank-Erik de Leeuw; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

7.  Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study.

Authors:  Ya-Ping Huang; Li-Sheng Chen; Ming-Fang Yen; Ching-Yuan Fann; Yueh-Hsia Chiu; Hsiu-Hsi Chen; Shin-Liang Pan
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

8.  Parkinsonism and tremor disorders. A clinical approach.

Authors:  Hani Ts Benamer
Journal:  Libyan J Med       Date:  2007-06-01       Impact factor: 1.657

Review 9.  Alcohol Consumption and Parkinson's Disease Risk: A Review of Recent Findings.

Authors:  Silvana S Bettiol; Tanith C Rose; Clarissa J Hughes; Lesley A Smith
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

10.  Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients.

Authors:  Qiang Wei; Honghao Wang; Yanghua Tian; Fangcheng Xu; Xianwen Chen; Kai Wang
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.